Armata Pharmaceuticals (ARMP) EBIT Margin (2013 - 2020)
Armata Pharmaceuticals (ARMP) posted EBIT Margin of -14806.45% for Q2 2020.
Powered by 
Analysis
Armata Pharmaceuticals (ARMP) EBIT Margin (2013 - 2020) Analysis & Trends
For the trailing twelve months through Jun 30, 2020, EBIT Margin at Armata Pharmaceuticals was -17661.54%; for FY2017, it came in at -14048.70%, down 5057.16 percentage points from FY2016.
- Annual EBIT Margin shows a four-year change of +1240.19 percentage points (FY2013 to FY2017).
- In prior years, Armata Pharmaceuticals' EBIT Margin was -8991.54% in FY2016 (-6838.49 pp), -2153.05% in FY2015 (+1296.83 pp), -3449.88% in FY2014 (+11839.01 pp) and -15288.89% in FY2013.
- The Q2 2020 figure stands as the highest quarterly EBIT Margin since Q4 2017.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2017, with a gain of 42102.27 percentage points; the weakest was Q4 2016, with a drop of 51630.40 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Armata Pharmaceuticals | 133.35 Mn | 81.07 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | -14,806.45% |
| Dec 31, 2017 | -11,825.00% |
| Sep 30, 2017 | -1,963.16% |
| Jun 30, 2017 | -34,592.86% |
| Mar 31, 2017 | -11,582.76% |
| Dec 31, 2016 | -53,927.27% |
| Sep 30, 2016 | -11,748.28% |
| Jun 30, 2016 | -3,484.47% |
| Mar 31, 2016 | -4,262.26% |
| Dec 31, 2015 | -2,296.88% |
| Sep 30, 2015 | -1,697.90% |
| Jun 30, 2015 | -2,541.18% |
| Mar 31, 2015 | -2,222.55% |
| Dec 31, 2014 | -2,571.29% |
| Sep 30, 2014 | -5,078.64% |
| Jun 30, 2014 | -3,710.89% |
| Mar 31, 2014 | -2,436.54% |
| Sep 30, 2013 | -78,033.33% |
| Jun 30, 2013 | -1,950.32% |
| Mar 31, 2013 | -6,059.09% |
API Access
Armata Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ARMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ARMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ARMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();